Maqola

Reprogramming Tumor-Associated Macrophages To Reverse EGFR<sup>T790M</sup> Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat

Huige PengShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaBinfan ChenShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaWei HuangShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaYubo TangShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaYifan JiangShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaWenyuan ZhangShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaYongzhuo HuangShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

2017en

ABI

Annotatsiya

-caused resistance to tyrosine kinase inhibitor treatment.

Hali tarjima qilinmagan

Identifikatorlar

DOI: 10.1021/acs.nanolett.7b03756

Iqtiboslar va manbalar

3 ta iqtibos0 ta foydalanilgan manba

Koʻrsatkichlar — AkademScholar